RVL Pharmaceuticals
Colleen Daily is a seasoned sales and account management professional with extensive experience in the pharmaceutical industry. Currently serving as a Key Account Manager at Harrow since September 2022 and as a Senior Specialty Eye Care Territory Manager at RVL Pharmaceuticals since July 2020, Colleen has demonstrated exceptional skills in driving sales growth, particularly with the launch of Upneeq, achieving top rankings nationally and regionally. Prior roles include Senior Specialty Neuroscience Sales Representative at Vertical Pharmaceuticals, where Colleen excelled in promoting a diverse product portfolio, and sales positions at inVentiv Health, AstraZeneca, and Sunovion Pharmaceuticals, consistently exceeding performance targets and cultivating strong relationships with healthcare professionals. Colleen holds a Bachelor's degree in Social Sciences from Rosemont College and completed high school at Concord Carlisle High School.
This person is not in any offices
RVL Pharmaceuticals
RVL Pharmaceuticals plc is a specialty pharmaceutical company focused on the commercialization and development of products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas. The Company is currently commercializing UPNEEQ® (oxymetazoline hydrocholoride ophthalmic solution), 0.1%, for the treatment of acquired blepharoptosis, or low-lying eyelid, in adults. UPNEEQ is the first non-surgical treatment option approved by the FDA for acquired blepharoptosis.